{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:02:01Z","timestamp":1780326121447,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphatic metastasis is strongly associated with poor prognosis. Although the chemokine receptor CCR7 is a well-established promoter of lymphatic dissemination, its prognostic relevance remains weak. We show that tumour cell plasticity, defined by podoplanin (PDPN)-expression and promoted by hypoxia, intersects with CCR7 function in triple-negative breast cancer (TNBC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In vivo and in vitro studies using a CCR7-expressing TNBC mouse model were combined with transcriptomic profiling. Human relevance was assessed using scRNA-seq datasets from cell lines and primary tumours, as well as METABRIC breast cancer cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A PDPN-defined tumour cell mesenchymal shift, promoted by hypoxia, was required for efficient CCR7-driven lymphatic metastasis and tumour progression. PDPN-expression was linked to tumour cell collagen-expression and suppression of interferon-signalling, features associated with an immune-cold microenvironment. PDPN-expression with effects on interferon and collagen programmes was observed across murine and human TNBC cell lines and correlated with hypoxia signatures in primary TNBC, mirroring murine findings. In METABRIC, a high combined CCR7\u2013PDPN score predicted poor survival in lymph node\u2013positive patients, whereas either marker alone lacked prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PDPN is a tumour cell-associated biomarker of plasticity in TNBC, revealing synergy between hypoxia-induced mesenchymal phenotypic shifts and CCR7 in promoting lymphatic dissemination and poor prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03402-4","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:59:19Z","timestamp":1775757559000},"page":"1730-1743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Podoplanin-defined tumour plasticity and CCR7-mediated lymphatic metastasis in triple-negative breast cancer"],"prefix":"10.1038","volume":"134","author":[{"given":"Zhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Martine","family":"Ingebriktsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Bekkhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyusong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Queiro-Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Bazioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail Angelos","family":"Panagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vigorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim Harry","family":"Lehrstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dimberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-5715","authenticated-orcid":false,"given":"Elisabeth","family":"Wik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-765X","authenticated-orcid":false,"given":"Erling Andre","family":"Hoivik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Fuxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-0978","authenticated-orcid":false,"given":"Maria H.","family":"Ulvmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"3402_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5:66.","journal-title":"Nat Rev Dis Primers"},{"key":"3402_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181\u20137.","journal-title":"Cancer"},{"key":"3402_CR3","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi C, Chan TA, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42:1825\u201363.","journal-title":"Cancer Cell"},{"key":"3402_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21:162\u201380.","journal-title":"Nat Rev Cancer"},{"key":"3402_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/1878-0261.12092","volume":"11","author":"MC Karlsson","year":"2017","unstructured":"Karlsson MC, Gonzalez SF, Welin J, Fuxe J. Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system. Mol Oncol. 2017;11:781\u201391.","journal-title":"Mol Oncol"},{"key":"3402_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"3402_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg3551","volume":"6","author":"H du Bois","year":"2021","unstructured":"du Bois H, Heim TA, Lund AW. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci Immunol. 2021;6:eabg3551.","journal-title":"Sci Immunol"},{"key":"3402_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50\u20136.","journal-title":"Nature"},{"key":"3402_CR9","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-05-0014","volume":"11","author":"N Cabioglu","year":"2005","unstructured":"Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE, et al. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res. 2005;11:5686\u201393.","journal-title":"Clin Cancer Res"},{"key":"3402_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","volume":"11","author":"JD Shields","year":"2007","unstructured":"Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell. 2007;11:526\u201338.","journal-title":"Cancer Cell"},{"key":"3402_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-9966-29-16","volume":"29","author":"Y Liu","year":"2010","unstructured":"Liu Y, Ji R, Li J, Gu Q, Zhao X, Sun T, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010;29:16.","journal-title":"J Exp Clin Cancer Res"},{"key":"3402_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1593\/tlo.10178","volume":"3","author":"HD Cunningham","year":"2010","unstructured":"Cunningham HD, Shannon LA, Calloway PA, Fassold BC, Dunwiddie I, Vielhauer G, et al. Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. Transl Oncol. 2010;3:354\u201361.","journal-title":"Transl Oncol"},{"key":"3402_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","volume":"21","author":"L Ohl","year":"2004","unstructured":"Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity. 2004;21:279\u201388.","journal-title":"Immunity"},{"key":"3402_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","volume":"99","author":"R Forster","year":"1999","unstructured":"Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99:23\u201333.","journal-title":"Cell"},{"key":"3402_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/onc.2015.133","volume":"35","author":"MF Pang","year":"2016","unstructured":"Pang MF, Georgoudaki AM, Lambut L, Johansson J, Tabor V, Hagikura K, et al. TGF-beta1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7\/CCL21-mediated chemotaxis. Oncogene. 2016;35:748\u201360.","journal-title":"Oncogene"},{"key":"3402_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/cjp2.65","volume":"3","author":"SN Sonbul","year":"2017","unstructured":"Sonbul SN, Gorringe KL, Aleskandarany MA, Mukherjee A, Green AR, Ellis IO, et al. Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma. J Pathol Clin Res. 2017;3:105\u201314.","journal-title":"J Pathol Clin Res"},{"key":"3402_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1189\/jlb.3MA0815-373R","volume":"99","author":"P Weitzenfeld","year":"2016","unstructured":"Weitzenfeld P, Kossover O, Korner C, Meshel T, Wiemann S, Seliktar D, et al. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors. J Leukoc Biol. 2016;99:1009\u201325.","journal-title":"J Leukoc Biol"},{"key":"3402_CR18","first-page":"237","volume":"8","author":"CN Johnstone","year":"2015","unstructured":"Johnstone CN, Smith YE, Cao Y, Burrows AD, Cross RS, Ling X, et al. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL\/6-mouse-derived model of spontaneously metastatic mammary cancer. Dis Model Mech. 2015;8:237\u201351.","journal-title":"Dis Model Mech"},{"key":"3402_CR19","doi-asserted-by":"publisher","first-page":"8074","DOI":"10.1002\/cam4.3295","volume":"9","author":"A Le Naour","year":"2020","unstructured":"Le Naour A, Rossary A, Vasson M-P. EO771, is it a well-characterized cell line for mouse mammary cancer model? Limit and uncertainty. Cancer Med. 2020;9:8074\u201385.","journal-title":"Cancer Med"},{"key":"3402_CR20","doi-asserted-by":"publisher","first-page":"e1421891","DOI":"10.1080\/2162402X.2017.1421891","volume":"7","author":"EJ Crosby","year":"2018","unstructured":"Crosby EJ, Wei J, Yang XY, Lei G, Wang T, Liu CX, et al. Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors. Oncoimmunology. 2018;7:e1421891.","journal-title":"Oncoimmunology"},{"key":"3402_CR21","doi-asserted-by":"crossref","unstructured":"Quintanilla M, Montero-Montero L, Renart J, Martin-Villar E. Podoplanin in inflammation and cancer. Int J Mol Sci. 2019;20:707.","DOI":"10.3390\/ijms20030707"},{"key":"3402_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0002-9440(10)65285-6","volume":"154","author":"S Breiteneder-Geleff","year":"1999","unstructured":"Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385\u201394.","journal-title":"Am J Pathol"},{"key":"3402_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41423-023-00980-8","volume":"20","author":"Y Gu","year":"2023","unstructured":"Gu Y, Zhang Z, ten Dijke P. Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy. Cell Mol Immunol. 2023;20:318\u201340.","journal-title":"Cell Mol Immunol"},{"key":"3402_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","volume":"25","author":"X Ye","year":"2015","unstructured":"Ye X, Weinberg RA. Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 2015;25:675\u201386.","journal-title":"Trends Cell Biol"},{"key":"3402_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/10799890802679876","volume":"29","author":"I Sur","year":"2009","unstructured":"Sur I, Ulvmar M, Jungedal R, Toftgard R. Inhibition of NF-kappaB signaling interferes with phorbol ester-induced growth arrest of keratinocytes in a TNFR1-independent manner. J Recept Signal Transduct Res. 2009;29:44\u201351.","journal-title":"J Recept Signal Transduct Res"},{"key":"3402_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/oxygen1010006","volume":"1","author":"H Rinderknecht","year":"2021","unstructured":"Rinderknecht H, Ehnert S, Braun B, Histing T, Nussler AK, Linnemann C. The art of inducing hypoxia. Oxygen. 2021;1:46\u201361.","journal-title":"Oxygen"},{"key":"3402_CR27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347.","journal-title":"Nat Genet"},{"key":"3402_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.5981","volume":"258","author":"T Bekkhus","year":"2022","unstructured":"Bekkhus T, Avenel C, Hanna S, Franzen Boger M, Klemm A, Bacovia DV, et al. Automated detection of vascular remodeling in tumor-draining lymph nodes by the deep-learning tool HEV-finder. J Pathol. 2022;258:4\u201311.","journal-title":"J Pathol"},{"key":"3402_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1182\/blood-2010-07-298562","volume":"117","author":"I Choi","year":"2011","unstructured":"Choi I, Chung HK, Ramu S, Lee HN, Kim KE, Lee S, et al. Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood. 2011;117:362\u20135.","journal-title":"Blood"},{"key":"3402_CR30","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102:1555\u201377.","journal-title":"Br J Cancer"},{"key":"3402_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcvm.2020.00052","volume":"7","author":"M Xiang","year":"2020","unstructured":"Xiang M, Grosso RA, Takeda A, Pan J, Bekkhus T, Brulois K, et al. A single-cell transcriptional roadmap of the mouse and human lymph node lymphatic vasculature. Front Cardiovasc Med. 2020;7:52.","journal-title":"Front Cardiovasc Med"},{"key":"3402_CR32","doi-asserted-by":"crossref","unstructured":"Bekkhus T, Martikainen T, Olofsson A, Franzen Boger M, Vasiliu Bacovia D, Warnberg F, et al. Remodeling of the lymph node high endothelial venules reflects tumor invasiveness in breast cancer and is associated with dysregulation of perivascular stromal cells. Cancers. 2021;13:211.","DOI":"10.3390\/cancers13020211"},{"key":"3402_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346\u201352.","journal-title":"Nature"},{"key":"3402_CR34","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3402_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3402_CR36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/cells11040656","volume":"11","author":"CA Bill","year":"2022","unstructured":"Bill CA, Allen CM, Vines CM. C-C chemokine receptor 7 in cancer. Cells. 2022;11:656.","journal-title":"Cells"},{"key":"3402_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.825287","volume":"13","author":"DAP Louie","year":"2022","unstructured":"Louie DAP, Oo D, Leung G, Lin Y, Stephens M, Alrashed O, et al. Tumor-draining lymph node reconstruction promotes B cell activation during E0771 mouse breast cancer growth. Front Pharmacol. 2022;13:825287.","journal-title":"Front Pharmacol"},{"key":"3402_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri3689","volume":"14","author":"BA Heesters","year":"2014","unstructured":"Heesters BA, Myers RC, Carroll MC. Follicular dendritic cells: dynamic antigen libraries. Nat Rev Immunol. 2014;14:495\u2013504.","journal-title":"Nat Rev Immunol"},{"key":"3402_CR39","doi-asserted-by":"crossref","unstructured":"Bresson L, Faraldo MM, Di-Cicco A, Quintanilla M, Glukhova MA, Deugnier MA. Podoplanin regulates mammary stem cell function and tumorigenesis by potentiating Wnt\/beta-catenin signaling. Development. 2018;145:dev160382.","DOI":"10.1242\/dev.160382"},{"key":"3402_CR40","doi-asserted-by":"crossref","unstructured":"Adrover JM, Han X, Sun L, Fujii T, Sivetz N, Dassler-Plenker J, et al. Neutrophils drive vascular occlusion, tumour necrosis and metastasis. Nature. 2025;645:484\u201395.","DOI":"10.1038\/s41586-025-09278-3"},{"key":"3402_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","volume":"21","author":"IS Kim","year":"2019","unstructured":"Kim IS, Gao Y, Welte T, Wang H, Liu J, Janghorban M, et al. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol. 2019;21:1113\u201326.","journal-title":"Nat Cell Biol"},{"key":"3402_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1\u201310.","journal-title":"Immunity"},{"key":"3402_CR43","doi-asserted-by":"crossref","unstructured":"Rasmussen M, Alvik K, Kannen V, Olafsen NE, Erlingsson LAM, Grimaldi G, et al. Loss of PARP7 increases type I interferon signaling in EO771 breast cancer cells and prevents mammary tumor growth by increasing antitumor immunity. Cancers. 2023;15:3689.","DOI":"10.3390\/cancers15143689"},{"key":"3402_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.immuni.2010.12.016","volume":"34","author":"RP Kataru","year":"2011","unstructured":"Kataru RP, Kim H, Jang C, Choi DK, Koh BI, Kim M, et al. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity. 2011;34:96\u2013107.","journal-title":"Immunity"},{"key":"3402_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29358-6","volume":"13","author":"G Gambardella","year":"2022","unstructured":"Gambardella G, Viscido G, Tumaini B, Isacchi A, Bosotti R, di Bernardo D. A single-cell analysis of breast cancer cell lines to study tumour heterogeneity and drug response. Nat Commun. 2022;13:1714.","journal-title":"Nat Commun"},{"key":"3402_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102935","volume":"24","author":"HL Rocha","year":"2021","unstructured":"Rocha HL, Godet I, Kurtoglu F, Metzcar J, Konstantinopoulos K, Bhoyar S, et al. A persistent invasive phenotype in post-hypoxic tumor cells is revealed by fate mapping and computational modeling. iScience. 2021;24:102935.","journal-title":"iScience"},{"key":"3402_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2020.05.012","volume":"487","author":"RY Hapke","year":"2020","unstructured":"Hapke RY, Haake SM. Hypoxia-induced epithelial to mesenchymal transition in cancer. Cancer Lett. 2020;487:10\u201320.","journal-title":"Cancer Lett"},{"key":"3402_CR48","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.ccell.2021.06.018","volume":"39","author":"JM Gozgit","year":"2021","unstructured":"Gozgit JM, Vasbinder MM, Abo RP, Kunii K, Kuplast-Barr KG, Gui B, et al. PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity. Cancer Cell. 2021;39:1214\u201326.e10.","journal-title":"Cancer Cell"},{"key":"3402_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","volume":"10","author":"J Kwon","year":"2020","unstructured":"Kwon J, Bakhoum SF. The cytosolic DNA-sensing cGAS\u2013STING pathway in cancer. Cancer Discov. 2020;10:26\u201339.","journal-title":"Cancer Discov"},{"key":"3402_CR50","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41586-023-05880-5","volume":"616","author":"J Hu","year":"2023","unstructured":"Hu J, S\u00e1nchez-Rivera FJ, Wang Z, Johnson GN, Ho YJ, Ganesh K, et al. STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature. 2023;616:806\u201313.","journal-title":"Nature"},{"key":"3402_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115908","volume":"44","author":"S Makris","year":"2025","unstructured":"Makris S, Hari-Gupta Y, Cantoral-Rebordinos JA, Martinez VG, Horsnell HL, Benjamin AC, et al. Lymph node fibroblast phenotypes and immune crosstalk regulated by podoplanin activity. Cell Rep. 2025;44:115908.","journal-title":"Cell Rep"},{"key":"3402_CR52","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.2147\/IJGM.S463649","volume":"17","author":"X Li","year":"2024","unstructured":"Li X, Jin Y, Xue J. Unveiling collagen\u2019s role in breast cancer: insights into expression patterns, functions and clinical implications. Int J Gen Med. 2024;17:1773\u201387.","journal-title":"Int J Gen Med"},{"key":"3402_CR53","doi-asserted-by":"crossref","unstructured":"Papalazarou V, Drew J, Juin A, Spence HJ, Whitelaw J, Nixon C, et al. Collagen VI expression is negatively mechanosensitive in pancreatic cancer cells and supports the metastatic niche. J Cell Sci. 2022;135:jcs259978.","DOI":"10.1242\/jcs.259978"},{"key":"3402_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01353-z","volume":"22","author":"TP Reddy","year":"2020","unstructured":"Reddy TP, Rosato RR, Li X, Moulder S, Piwnica-Worms H, Chang JC. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res. 2020;22:121.","journal-title":"Breast Cancer Res"},{"key":"3402_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01608-5","volume":"25","author":"H-C Lien","year":"2023","unstructured":"Lien H-C, Hsu C-L, Lu Y-S, Chen TW-W, Chen IC, Li Y-C, et al. Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma. Breast Cancer Res. 2023;25:11.","journal-title":"Breast Cancer Res"},{"key":"3402_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40478-5","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Ocadiz-Ruiz R, Hall MS, Bushnell GG, Orbach SM, Decker JT, et al. A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs. Nat Commun. 2023;14:4790.","journal-title":"Nat Commun"},{"key":"3402_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-01983-4","volume":"13","author":"L Liu","year":"2025","unstructured":"Liu L, He Y, Du H, Tang M, Wang T, Tan J, et al. Biological profile of breast cancer brain metastasis. Acta Neuropathol Commun. 2025;13:78.","journal-title":"Acta Neuropathol Commun"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03402-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03402-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03402-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:03:42Z","timestamp":1780322622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03402-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,6,20]]}},"alternative-id":["3402"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03402-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All in vivo procedures were approved by the Uppsala County Regional Ethics Committee (Dnr: 6009\/17 MHU and 5.8.18-03169.2023 MHU and 5.8.18-16487\/2024 AD). Use of the METABRIC cohorts was approved by the METABRIC Data Access Committee (2015); no additional approvals were required. The approval to use archival biobank LNs was provided by the Uppsala regional ethics committee, 2017\/061 and addition 2017\/061:1 and 2017\/061:2 to MHU. This study was conducted in accordance with the Declaration of Helsinki and the Swedish Ethical Review Act and the Swedish Biobank Act (2023:38) and with approval from Uppsala Biobank. In accordance with the Swedish Biobank Act, all patients were informed about biobank storage and their right to restrict or withdraw consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided their consent to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}